1. Polymeric Micelles Employing Platinum(II) Linker for the Delivery of the Kinase Inhibitor Dactolisib
- Author
-
Shi, Haili, Lou, Bo, van Steenbergen, Mies J., Sijbrandi, Niels J., Hennink, Wim E., Kok, Robbert J., Afd Pharmaceutics, Pharmaceutics, Afd Pharmaceutics, and Pharmaceutics
- Subjects
Chemistry(all) ,Ethylenediamine ,02 engineering and technology ,Micelle ,chemistry.chemical_compound ,020401 chemical engineering ,Materials Science(all) ,PEG ratio ,kinase inhibitors ,General Materials Science ,0204 chemical engineering ,Acrylic acid ,polymeric micelles ,Chemistry ,General Chemistry ,021001 nanoscience & nanotechnology ,Condensed Matter Physics ,Drug delivery ,drug delivery ,coordination chemistry ,polymer–metal complexes ,Nanocarriers ,0210 nano-technology ,Linker ,Ethylene glycol ,Nuclear chemistry - Abstract
Polymeric micelles are attractive nanocarriers for hydrophobic drug molecules such as the kinase inhibitor dactolisib. Two different poly(ethylene glycol)–poly(acrylic acid) (PEG-b-PAA) block-copolymers are synthesized, PEG(5400)-b-PAA(2000) and PEG(10000)-b-PAA(3700), respectively. Polymeric micelles are formed by self-assembly once dactolisib is conjugated via the ethylenediamine platinum(II) linker (Lx) to the PAA block of the block copolymers. Dactolisib micelles with dactolisib loading content of 17% w/w show good colloidal stability and display sustained release of Lx-dactolisib over 96 h in PBS at 37 °C, while media containing reagents that compete for platinum coordination (e.g., glutathione (GSH) or dithiothreitol (DTT)) effectuate release of the parent inhibitor dactolisib at similar release rates. Dactolisib/lissamine-loaded micelles are internalized by human breast adenocarcinoma cells (MCF-7) in a dose and time-dependent manner as demonstrated by confocal microscopy. Dactolisib-loaded micelles inhibit the PI3K/mTOR signaling pathway at low concentrations (400 × 10−9 m) and exhibit potent cytotoxicity against MCF-7 cells with IC50 values of 462 ± 46 and 755 ± 75 × 10−9 m for micelles with either short or longer PEG-b-PAA block lengths. In conclusion, dactolisib loaded PEG-b-PAA micelles are successfully prepared and hold potential for nanomedicine-based tumor delivery of dactolisib.
- Published
- 2019